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SUMMARY
Stress is a known trigger for flares of inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS);
however, this process is not well understood. Here, we find that restraint stress in mice leads to signs of diar-
rhea, fecal dysbiosis, and a barrier defect via the opening of goblet-cell associated passages. Notably, stress
increases host immunity to gut bacteria as assessed by immunoglobulin A (IgA)-bound gut bacteria. Stress-
induced microbial changes are necessary and sufficient to elicit these effects. Moreover, similar to mice,
many diarrhea-predominant IBS (IBS-D) patients from two cohorts display increased antibacterial immunity
as assessed by IgA-bound fecal bacteria. This antibacterial IgA response in IBS-D correlates with somatic
symptom severity and was distinct from healthy controls or IBD patients. These findings suggest that stress
may play an important role in patients with IgA-associated IBS-D by disrupting the intestinal microbial com-
munity that alters gastrointestinal function and host immunity to commensal bacteria.
INTRODUCTION
The intestinal tract harbors trillions of commensal bacteria that
provide beneficial functions to the host, including nutrient meta-
bolism and protection from infection by pathogenic organisms.
The close proximity of these bacteria presents a unique chal-
lenge to the immune system, as it must develop appropriately
tolerogenic responses against commensal organisms while
generating inflammatory reactions against pathogenic bacte-
ria.1–3 Homeostasis involves peripheral regulatory T (Treg)
cells4–6 and protective immunoglobulin responses7–10 that react
to commensal bacterial antigens. Thus, immune interactions
with gut bacteria play an important role in maintaining proper ho-
meostasis and preventing intestinal disease.
Although host genetics and microbial composition are most
often thought of as being important for host:commensal interac-
tions, physiologic stress has been hypothesized to play a role in
contributing to immune-mediated gastrointestinal (GI) diseases.
For example, stress is reported to trigger flares of inflammatory
bowel disease (IBD).11,12 Murine studies have also supported
the notion that stress can affect gut homeostasis. The induction
of stress via physical restraint or social stressor exposure has
been shown to induce alterations in the gut microbial community
and increase susceptibility to intestinal infections.13–15 Thus, ev-
idence from humans and mice suggests that stress can modu-
late immune-mediated intestinal disease.
In addition, stress is well established as a potential trigger for
irritable bowel syndrome (IBS),16–18 a common human GI disor-
der that is characterized by chronic abdominal pain and altered
bowel patterns. Like IBD, alterations in the intestinal microbiota
have been reported in IBS patients.19,20 In fact, a recent report
showed that the transfer of fecal microbiota from diarrhea-pre-
dominant IBS (IBS-D) patients into germ-free (GF) mice leads
to the transference of altered gut motility, intestinal barrier
dysfunction, and anxiety-like behaviors,21 suggesting that mi-
crobial alterations may have mechanistic relevance to some of
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the symptoms of IBS-D. Thus, IBS-D is a condition associated
with stress, microbial changes, and abnormal GI function.
In contrast to IBD, IBS-D occurs in the absence of an overt
inflammation or other abnormality seen by intestinal biopsy, radi-
ography, or serum laboratory studies.16,22 Research studies
have suggested some alterations in gut immune homeostasis
in IBS. For example, a subset of IBS patients display increased
intestinal permeability.19,20 Similarly, increases in mast cells
and other immune cell populations have also been described
in small studies.23,24 Approximately 10% of IBS patients have
symptoms following an episode of infectious diarrhea. In these
post-infection IBS patients, host gene expression studies from
rectal biopsies showed alterations in the pathways of cell junc-
tion integrity and general inflammatory response.25,26 Finally, an-
tibodies to vinculin and cytolethal distending toxin B (CdtB) have
been reported to be increased in IBS patients.27 However, there
exists relatively little evidence for host immune activation against
gut bacteria in IBS in comparison to IBD.
Given the reported association of stress with alterations in the
gut microbiota, we hypothesized that stress could modulate the
host immune response to gut microbes. To test this, we used a
murine restraint stressmodel.28We found that stress induced al-
terations in the gut community, signs of diarrhea, translocation of
live gut resident bacteria, and evidence of increased immune re-
sponses against gut bacteria, with increased immunoglobulin A
(IgA) bound to luminal bacteria. Human IBS-D patients exhibited
many of the features seen in stressedmice, such as diarrhea and
altered microbiota. Notably, a subset of patients showed
increased IgA-bound bacteria, which were unique as compared
to IgA-bound bacteria of control or IBD patients. In summary, our
human and mouse data suggest a model by which stress in-
duces gut community changes that trigger intestinal immune re-
sponses and altered GI physiology.
RESULTS
Murine Stress Leads to Alterations in GI Motility and
Antibacterial Immunity
To study the effects of stress on the intestinal microbiota and im-
mune system, we used a previously characterized restraint
model that does not physically harm the animal and is reported
to alter the gut bacterial composition.13,15 This model also in-
duces characteristics of physiologic stress, including increased
corticosteroid levels, behavioral alterations in mice, and
decreased weight gain.29 As restraint prevents access to food
andwater, we implemented a 2-h/day restraint period (Figure 1A)
to minimize the impact of altered feeding patterns on the micro-
biota. Consistent with previous studies,30 we observed delayed
weight gain during the period of stress (Figure 1B).We also noted
that stressed mice had softer stool, consistent with diarrhea,
which we quantified by observing an increase in the percentage
of water in feces and an increase in fecal pellets output over 2 h
(Figure 1C). Thus, this stress model induced alterations in GI
physiology with diarrheal features.
We next examined whether stress affected the adaptive
mucosal immune system. We did not observe marked changes
in the frequency of effector CD44hi or Foxp3+ Treg populations
in the distal cecum/colon draining mesenteric lymph node
(cdMLN) or the more proximal small intestinal draining mesen-
teric lymph nodes (siMLNs) (Figure S1A). However, there were
changes in the development of naive T cells reactive to Helico-
bacter, a mucosally dominant bacteria in our mice that are
continuously exposed to the adaptive immune system.31 The
transfer of naive Helicobacter-reactive CT2 T cell receptor
(TCR) Tg cells32 on day 5 of stress revealed decreased peripheral
Treg (pTreg) cell induction in the cdMLN with stress (Figures 1D
and S1B). This decreased conversion did not appear to be due to
differences in antigen exposure, as CT2 cells divided to the same
degree in both control and stressed animals (Figure S1C). Thus,
while the overall proportion of effector to Treg cells appears to be
maintained, stress limits peripheral Treg cell generation to at
least one commensal bacterial species.
We then assessed the effect of stress on gut B cell responses
by analyzing the frequency of intestinal bacteria bound in situ to
IgA or IgG via flow cytometry.33–35 Notably, we observed an in-
crease in the frequency of IgA-bound bacteria in stressed mice
(Figures 1E and S1D). This increase was not simply a reflection
of increased IgA secretion or accumulation in the feces, as free
fecal IgA was unchanged (Figure S1E). The inhibition of pTreg
cell selection and increased IgA responses could be secondary
to intestinal inflammation. However, we did not observe overt
signs of inflammation such as ulceration, edema, or increased
mononuclear cell infiltrates by histology (Figure 1F). We did not
attempt to elicit immunopathology with further stress, as stress
is not thought to directly cause immune-mediated diseases,
even though it likely modulates them.16,22 We also asked
whether diarrheal-like symptoms that occurred after stress could
themselves lead to increased IgA responses to gut bacteria.
However, the administration of cholera toxin, which leads to a
secretory diarrhea as evidenced by increased fecal water weight
(Figure 1G) in the range seen in our stress protocol (Figure 1C),
did not markedly increase the frequency of IgA+ fecal bacteria
(Figure 1G). Thus, these murine data suggest that stress can
induce immune activation to gut bacteria without overt intestinal
inflammation.
Murine Stress-Induced Dysbiosis Leads to Colonic
Barrier Dysfunction through Open Colonic GAPs
The increase in IgA-bound bacteria implied that experimental
stress promoted bacterial interactions with the adaptive immune
system. This interaction could be mediated by decreased
mucosal barrier function, which has previously been reported
for murine stress models.36 We therefore tested whether stress
could directly lead to bacteria translocating across the mucosal
barrier and into the MLNs. Whereas control mice had sterile
cdMLNs, we consistently observed 200–1,200 aerobic colony-
forming units (CFUs) from stressedmice (Figure 2A). As histology
did not suggest a marked barrier breach due to epithelial cell
damage after stress (Figure 1F), we evaluated whether colonic
goblet cell-associated passages (GAPs) could be a mechanism
for bacterial transport across the epithelium.37 Colonic GAPs
are normally inhibited by goblet cell-intrinsic Myd88-dependent
sensing of the gut microbiota, which suppresses the ability of
goblet cells to respond to acetylcholine (ACh), the stimulus
driving GAP formation at steady state.38 In stressed mice,
colonic GAPs were readily observed by day 3, increasing in
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frequency by day 7 in the proximal colon (Figure 2B). Open GAPs
in the colon have been associated with increased luminal antigen
delivery.39 Consistent with this, we observed the increased
expansion of OTII cells in response to ovalbumin administered
per rectum (p.r.) in stressed mice (Figures 2C and S1F). Further-
more, when GAP formation was induced in the absence of stress
using an epidermal growth factor receptor inhibitor (EGFRi),38
there was a significant increase in bacteria targeted by IgA (Fig-
ure 2D). Thus, these data show that stress induces GAP forma-
tion and bacterial translocation and that in a physiologic state,
GAP opening can lead to increased antibacterial IgA.
We next sought to understand how stress may lead to the
opening of colonic GAPs. Using colon tissue explants from
stressedmice, we found that blockade of the ACh pathway using
muscarinic AChR antagonists led to GAP closure (Figure 2E). In
addition, GAPs could also be closed via the activation of the
EGFR, either directly via EGF or indirectly by lipopolysaccharide
(LPS)-induced MyD88 signaling, which inhibits responses to
ACh in goblet cells to form GAPs.38 These findings suggested
that the open GAPs in stressed mice could still be inhibited nor-
mally by theMyD88 bacterial sensing pathway, leading to the hy-
pothesis that stressed microbiota is unable to close colonic
GAPs. Using ex vivo explants of colonic segments from stressed
mice as described above, we found that cecal contents (CC)
collected from control mice closed GAPs, whereas CC from
day 7 stressed mice were ineffective (Figure 2F). A 1:2 mixture
of control and stressed CC was still capable of closing GAPs
(Figure 2G), suggesting that stressed CC did not contain signals
that dominantly opens GAPs, but rather are missing signals that
close GAPs. To assess whether the ACh/MyD88 pathway for
GAPs was operant in vivo with stress, we performed intra-rectal
administration of EGF after every stress period. EGF treatment
inhibited GAP formation and reduced bacterial translocation to
the cdMLN (Figure 2H). Thus, these data suggest that stress
directly or indirectly leads to a loss of luminal signals that nor-
mally mediate GAP closure, resulting in bacterial translocation.
We then assessed whether cecal contents from non-stressed
mice were directly involved in GAP formation in vivo. We admin-
istered CC p.r. daily immediately after each stress. Notably,
stressed mice receiving CC from non-stressed control donors
showed fewer open GAPs and lower levels of bacterial translo-
cation to the cdMLN (Figure 2I), suggesting that microbial
changes and not increased ACh signaling with stress40 may be
the dominant factor leading to open GAPs in stressed mice.
A B C
D E F G
Figure 1. Murine Stress Induces Weight Loss and Features of Diarrhea
(A) Murine restraint stressmodel. 50mL conical tubes with airholes were used for restraint for 2 h/day for 7 days. Food andwater were withheld from control mice.
(B–F) Effects of stress model.
(B) Body weight (% change, n = 8–9, 2-way repeated-measures ANOVA).
(C) GI function: percentage of fecal water weight and number of fecal pellets expelled in 2-h duration on day 8 (n = 8–9).
(D) Peripheral Treg cell induction to Helicobacter. 53 104 naive congenically marked CT2 TCR transgenic cells were transferred on day 5 of stress and analyzed
3 days later for the induction of Foxp3IRES-GFP in the cdMLN (n = 6). Mice were stressed for the usual 7 days.
(E) Fraction of IgA-bound fecal bacteria (d8, n = 8-9).
(F) Colon histology. Representative sections from day 8 stressed versus control mice are shown (n = 5).
(G) Cholera toxin-induced diarrhea. Cholera toxin (10 mg) per rectum (p.r.) was administered on days 1 and 4 and analyzed on day 7 for fecal water weight and%
IgA+ fecal bacteria (n = 5–7).
Data are presented as the mean ± SEM. Two to three independent experiments were performed and *p < 0.05 using Student’s t test unless otherwise indicated.
See also Figure S1.
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Stressed mice receiving CC from control mice also displayed a
decreased frequency of IgA-targeted bacteria and diarrhea fea-
tures suggested by a lower fecal water weight and fecal output
(Figures 2J and 2K). Thus, these data suggest that the microbial
dysbiosis that arises during stress leads to open GAPs and bac-
terial translocation, which provides a potential mechanism to
explain the increased immune responses to gut bacteria.
Transplant of Stressed Microbiota Is Sufficient to
Increase Antibacterial Immunity and Alter Gut Function
The above data suggested that the effects of stress in the gut are
largely mediated by the microbiome. To directly confirm this, we
stressed GF mice, which are reported to have an exaggerated
hypothalamic-pituitary-adrenal axis response to restraint
stress.41 Stressed GF mice exhibited a systemic physiological
A B C D
HGFE
I J K
Figure 2. Stress-Induced Dysbiosis Leads to GAP-Mediated Bacterial Translocation and Diarrheal Signs
(A) Stress-induced bacterial translocation. Aerobic colony-forming units (CFUs) were assessed in the cdMLN on the indicated days 1 h after stress (n = 4–6).
(B) Stress-induced GAPs. Number of open GAPs per crypt from the proximal colon of stressed mice on the indicated days were assessed by rhodamine-dextran
staining (n = 4–6).
(C) Presentation of GAP-dependent luminal antigens to T cells. Naive congenically marked OTII cells (105) were transferred on day 6 of stress, followed by 25 mg
ovalbumin p.r. on day 7, and analysis 3 days later for the percentage of OTII cells of all CD4 T cells in cdMLN (n = 5).
(D) Increased IgA+ fecal bacteria in non-stressed mice with open GAPs. GAP formation induced via intraperitoneal EGFRi injection for 7 days and IgA+ fecal
bacteria assessed on day 8 (n = 10, 3 experiments).
(E) Closure of GAPs via modulation of ACh/Myd88 pathway. Proximal colon explants, obtained from stressed mice 1 h after the last cycle on day 7, were treated
with pan or selective cholinergic antagonists (atropine, tropicamide), LPS, or EGF, and assessed for the number of open GAPs per crypt (n = 4–5).
(F andG) Closure of GAPs ex vivo by control cecal contents (CCs). Colon explants of stressedmice were treatedwith vehicle, control, or stressed CC (F) or varying
ratios of control and stressed CCs (G), and then assessed for GAPs (n = 4–6; Student’s t test comparing different ratios to vehicle treatment).
(H) EGF rescues GAP opening and bacterial translocation during stress. EGF was administered p.r. to mice after 2 h of stress every day, and on day 8 bacterial
translocation (CFUs in cdMLN) and open GAPs in proximal colon explants were assessed (n = 5–6, 2 expts).
(I–K) Fecal microbiota transplantation (FMT) partially rescues the effects of stress. Stressed mice were given repeated FMT p.r. of either stressed or control CCs
daily after each stress cycle and assessed for the following (n = 6–8): (I) bacterial translocation by CFUs in cdMLN and number of open GAPs in proximal colon
assessed 1–2 h after the last day of stress on day 7; (J) diarrhea signs by number of fecal pellets expelled during the 2-h stress cycle (average of days 6 and 7) and
percentage of fecal water weight assessed on day 7 before stress; and (K) frequency of IgA+ bacteria normalized to each experiment’s control FMT average
assessed on day 7 before stress.
The data are presented as means ± SEMs and Student’s t test. Two to three independent experiments for all of the panels. *p < 0.05, **p < 0.005, and
***p < 0.0005.
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change to stress as assessed by weight loss, albeit slower than
specific-pathogen-free (SPF) mice (Figure 3A). Notably, GI fea-
tures of diarrhea such as increased fecal water weight and fecal
output were not observed; instead stressed mice actually ex-
hibited decreased fecal water weight (Figure 3B). Thus, the pres-
ence of commensal bacteria is essential to observe the diarrheal
effects of stress.
The effect of dysbiosis on the gut could be dependent on
neuroendocrine effects of stress such as the induction of
ACh,42 which can also lead to opening of GAPs.38 To test
whether dysbiosis alone is sufficient, we performed fecal micro-
biota transplantation (FMT) of stressed or control fecal micro-
biota into GF mice without any concurrent restraint stress.
Compared to GF mice that received control CC, mice that
received stressed CC displayed diarrheal features with
increased fecal water weight and fecal output on day 7 after
the FMT (Figure 3C). Stressed FMT mice also displayed a trend
toward increased fecal antibacteria IgA (Figure 3D). Notably, mi-
crobiota from stressed, as compared to control, mice were not
as efficient at closing colonic GAPs generally open in GF
mice,38 allowing more bacterial translocation (Figure 3E). Dysbi-
oticmicrobiota from stressedmice alone is therefore sufficient to
phenocopy a number of features of stress when introduced into
GF mice. In total, these data suggest a model in which stress in-
duces gut microbial dysbiosis, which in turn triggers altered gut
motility, altered antibacterial immunity, and colonic barrier
alterations.
We further probed the role of the intestinal microbiome in the
response of the host to stress through a global analysis of host
gene transcription in colonic tissues during stress in SPF and
GF mice. In SPF mice, stress induces an increase in transcrip-
tional pathways involved in innate and adaptive immunity and
defense against organisms when compared with control SPF
or GF mice (Figures 3F and S3). In contrast, stress in GF mice
compared to non-stressed GF mice leads to the significant
downregulation of the same immune and defense pathways
F
A B C D E
Figure 3. Dysbiosis Induced by Stress Drives Intestinal and Immunological Alterations
(A and B) Effect of stress on germ-free (GF) mice. Stressed GF mice were assessed for the following: (A) change in body weight (n = 5, 1 expt.) and (B) GI function
assessed by the number of fecal pellets expelled in a 2-h duration and percentage of fecal water weight on day 8 (n = 10, 2 expts.).
(C–E) Microbiota are sufficient to induce features of stress. GFmice were transplanted via oral gavage with stressed or control CCs without concurrent stress and
assessed 7 days later for the following: (C) number of fecal pellets expelled in a 2-h duration and percentage of fecal water weight (n = 13, 2 expts); (D) percentage
of IgA-bound fecal bacteria (n = 7–8, 2 expts); and (E) number of GAPs per crypt in the proximal colon and CFUs in cdMLN (n = 8–13, 1 expt).
(F) Stress-induced biological processes in the colon. GF and SPF mice were stressed for 7 days. The following day, the entire colon and cecum with respective
unstressed controls was analyzed by RNA-seq (n = 3/group, 1 expt). The top 20 Gene Ontology processes created with Pathview with GAGE padj < 0.05
comparing SPF stressed versus control mice were chosen for display in red. The fold change for the same pathways (padj < 0.05) in GF stressed versus control
mice is displayed for comparison (black). The top 20 most significant genes (padj < 0.05) that were upregulated or downregulated in SPF stressed versus control
mice, with colors indicating the Gene Ontology processes categories in legend. All of the pathways with the category designations and involved genes can be
found in Data S2.
The data are presented as means ± SEMs, Student’s t test, and 2–3 independent experiments for all of the panels unless otherwise specified. *p < 0.05, **p <
0.005, and ***p < 0.0005. See also Figures S2 and S3.
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(Figures 3F and S3A). These pathways included cytokine re-
sponses (Ifi44, Ifit1, Gbp7, Ifit3, and Ifit3b), antigen processing
(Rnf213), and microbial defense (Parp14 and Slfn4) (Figure 3F).
Although we do not examine this issue further, stress is corre-
lated with decreased GO:anion transport in SPF mice (Figures
3F and S3B), which we speculate results in decreased water
resorption and increased fecal water. Conversely, stress in GF
mice increases anion transport, which is correlated with
decreased fecal water weight (Figure 3B). These results suggest
that the microbiota is crucial in driving gut immune responses
during stress.
Persistence of Bacterial Dysbiosis after Stress
These data suggested a model by which physiologic stress al-
ters themicrobiota that acutely leads to GAP opening, enhanced
adaptive immune responses, and features of diarrhea. We then
asked whether these biological effects persisted beyond the
period of stress. While fecal output normalized by 7 days after
the last stress period (day 14), fecal water weight was still
increased until day 14 post-stress (day 21; Figure 4A). Bacterial
translocation occurred 7 days after stress (day 14), but resolved
by day 21, which correlated with the closing of GAPs (Figure 4B).
Notably, the increase in IgA-targeted bacteria persisted 14 days
after stress (day 21; Figure 4C). Thus, the effects of stress on the
mucosal immune system and GI function persist after stress is
removed.
As the effect of stress on theGI tract was dependent on themi-
crobiota, we analyzed the changes in taxonomy by 16S rRNA
sequencing (rRNA-seq).43 We observed that 7 days of stress
leads to significant decreases in species richness, a component
of alpha diversity (Figure 4D), as well as overall microbial compo-
sition, with an increase in Bacteroidetes and a decrease in Firmi-
cutes families (Figure 4E; PERMANOVA = 0.001). These changes
were consistent with previous work using different periods of re-
straint stress.13 Notably, these changes in bacterial composition
persisted after the period of stress (Figures 4F and S4A).
We also examined whether the IgA+ bacteria fraction changed
during stress. We therefore used gradient boosted modeling
(GBM, see Method Details) to ask whether IgA enrichment can
predict stress as the experimental variable. Analysis of the com-
bined data from all three time points (days 8, 14, and 21) using
GBM revealed that the effect of stress had a clearly discernable
effect on operational taxonomic unit (OTU) frequency (i.e., dys-
biosis), or IgA enrichment (log2 (% OTU in IgA+/% in IgA))
(Figure 4G).
Examination of individual OTUs that were different between
the IgA+ and IgA 16S rRNA-seq data by both DESeq2 and
LEfSe analyses35 revealed several OTUs that showed increased
IgA binding with stress—particularly, Akkermansia mucinophila
(Figures 4H and S4B). In summary, these 16S rRNA data support
themodel that stress inmice leads to alteration in themicrobiota,
which is associated with changes in immunity to gut bacteria.
IBS-D Patients, Like Stressed Mice, Often Have
Increased IgA+ Bacteria
Although caution should be exercised in extrapolating results in
mice to humans, we noted that the murine stress model exhibits
many features of IBS-D, with increased fecal water weight and
fecal output (Figure 1C), microbial changes (Figures 4D–4F),
and a lack of overt features of inflammation on histology (Fig-
ure 1F).16,22 We also observed that stressed mice demonstrated
abdominal hyperalgesia to von Frey filament application (Fig-
ure 4I), which may be equivalent to the increased visceral hyper-
sensitivity described in IBS patients. These data suggest that
experimental stress in mice can induce phenotypic somatosen-
sory and GI effects reminiscent of human IBS-D.
In view of these similarities, we asked whether IBS-D patients
also demonstrated altered antibacterial IgA responses similar to
those observed in stressed mice. Enhanced IgA and IgG binding
to fecal bacterial has been reported for IBD.33,35We analyzed IgA
binding to fecal bacteria by flow cytometry from IBS-D patients
compared to age, gender, and geographically matched healthy
controls (Ctrl) from two geographical cohorts, St. Louis, Missouri
(STL) and Rochester, Minnesota (ROC).44
Notably, IBS-D patients displayed significantly higher IgA-
bound fecal bacteria than healthy individuals (Figure 5A), as
well as patients with intestinal (celiac sprue) and non-intestinal
(rheumatoid arthritis) immune disorders (Figure S5A). The STL
and ROC cohorts exhibited similar distributions of IgA-bound
bacteria (Figure S5B), suggesting that enhanced IgA targeting
is not dependent on geographic location. More important, these
data show that the enhanced IgA response in IBS-D is reproduc-
ible between two different medical centers, which can be amajor
issue, given the reliance on symptom-based criteria to make the
diagnosis of IBS.45 In addition to IgA-bound bacteria, IBS-D pa-
tients showed increased free fecal IgA (Figure S5C). Notably,
IBS-D patients showed a non-significant decrease in the fre-
quency of IgA-bound bacteria, but very little to no IgG-bound
bacteria compared to IBD patients (data from Rengarajan
et al.35) (Figure 5A). We hypothesize that these differences are
due to the lack of overt inflammation and frank mucosal barrier
breaches in IBS-D patients, which would permit IgG to access
the intestinal lumen.35 While our work was under review, a study
from China was published that also showed increased IgA-
bound bacteria in IBS-D patients compared to control.46 Thus,
these data confirm an enhanced intestinal immune response to
commensal bacteria in a subset of IBS-D patients reminiscent
of that seen in stressed mice.
IBS-D Patients Show Altered IgA Responses to Fecal
Bacteria
Consistent with prior reports,21,47 we observed bacterial alter-
ations inSTL IBS-Dpatientscomparedwithcontrols, asassessed
by both a decrease in alpha diversity and changes in composi-
tional beta diversity based on principal coordinates analysis
(PCoA) of UniFrac distances between individuals (PERMANOVA
p < 0.001 for both) (Figure 5B and 5C). We observed a decrease
in several families belonging to the Firmicutes phylum (unclassi-
fied [unc.] Clostridiales, unc. Firmicutes, andErysipelotrichaceae)
and an increase in one belonging to the Bacteroidetes phylum
(Porphyromonadaceae) (Figure S5D). Interestingly, a similar
contraction of Firmicutes and expansion of Bacteroidetes was
alsoobserved inour stressedanimals (Figure4E). Thus, IBS-Dpa-
tients exhibit microbial differences compared to healthy individ-
uals, which in some cases, corresponded with taxonomic differ-
ences observed in stressed animals.
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We next asked whether there were differences in the Ig-
bound (IgA or IgG) versus unbound bacterial in IBS-D patients
(STL + ROC). Analysis of Renyi entropy, an assessment of
alpha diversity, revealed that IBS-D patients exhibited
decreased diversity in both the Ig-bound and unbound frac-
tions (Figure S5E), similar to that seen with the analysis of the
total input 16S rRNA-seq (Figure 5B). Comparison of the Uni-
Frac distances between an individual’s Ig+ versus Ig microbial
populations revealed significant increases in IBS-D or IBD pa-
tients compared with control patients (Figure 5D), suggesting
that these diseases are associated with Ig specific to certain
taxa, leading to greater differences between the Ig-bound
and unbound fractions. Consistent with this hypothesis, the
Unifrac distance between an individual’s Ig+ versus Ig frac-
tions varied by the IgA+-bound frequency. IgA-hi IBS-D
patients, which we classified at >25% based on the control
population (Figure 5A, mean + 23 SD), showed significant in-
creases in the Unifrac distance between Ig+ and Ig fractions
Figure 4. The Effects of Stress on the Microbiota and Host Immunity Persist
(A–C) Persistent effects of stress. SPFmice stressed daily on days 1–7 as per Figure 1Awere assessed on days 14 and 21 for the following: (A) percentage of fecal
water weight and number of fecal pellets expelled in a 2-h duration (n = 8–9); (B) number of GAPs (n = 3–6) and bacterial translocation to the cdMLN (n = 3–6); and
(C) frequency of IgA-bound bacteria (n = 8).
(D–F) Dysbiosis in stressed mice. Fecal pellet 16S rRNA was sequenced and analyzed for day 8 stress versus control mice (n = 8–9). (D) Chao1 alpha diversity
index and (E) differentially enriched (Mann-Whitney U padj < 0.1) bacterial families. Boxes indicate the first and third quartiles (25th to 75th percentiles) and the
whiskers extend from the box hinge to the largest or smallest value no further than 1.5*interquartile range (IQR). (F) PCoA plots on unweighted Unifrac distance of
microbial composition from 16S rRNA sequences from stress and control mice at days 8, 14, and 21 (n = 8–9).
(G) Machine learning prediction using OTU frequency versus IgA enrichment ratio. A gradient boosted model (GBM, see Method Details) was generated on
a random 75% of the dataset (OTU frequency or IgA ratio for all days: 8, 14, and 21) and tested on the remaining 25%. The data shown are the average
prediction values of 160 runs, or 40/sample (25%). The IgA ratio (IgA+/IgA) is calculated as log2(%IgA+/%IgA) (see Method Details). One-way ANOVA with
Tukey’s (n = 24–28).
(H) IgA-enriched OTUs after stress. OTUs are selected based on being IgA enriched by both DESeq2 and LEfSe analysis (see Figure S4B) using data for all days
(Mann-Whitney U; n = 24–28; samples with 0 in IgA+ and IgA subsets not plotted).
(I) Stress-induced abdominal hypersensitivity. Shown are the percentage of mice with response for each von Frey filament at the indicated target forces on day 8
(n = 10 males), 2-way ANOVA p value.
Student’s t test was used unless otherwise indicated and 2–3 independent experiments for all of the panels unless otherwise specified. *p < 0.05, **p < 0.005, and
***p < 0.0005. See also Figure S4.
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compared with the IgA-lo IBS-D patients (Figures 5E and S5F).
Notably, the IgA-lo IBS-D subset was not clearly distinguish-
able from control patients by this metric (Figure 5D versus Fig-
ure 5E). Thus, these data suggest that IBS-D patients, and in
particular those with an IgA-hi phenotype, show altered Ig tar-
geting of specific bacteria.
Figure 5. IBS-D Patients Show Fecal Dysbiosis and Increased Ig Responses to Fecal Bacteria
(A–F) Fecal samples from patient cohorts from St. Louis (STL) and Rochester (ROC) were analyzed by flow and 16S rRNA sequencing (Ctrl = 34, IBS-D = 43,
IBD = 43).
(A) Increased IgA-bound bacteria in IBS-D. Percentage of IgA- and IgG-bound fecal bacteria seen by flow cytometry (Kruskal-Wallis with Dunn’s test). Each dot
represents a fecal specimen from one patient.
(B) Decreased microbial diversity in IBS-D. Chao1 alpha diversity index (means ± SEM). Chao1 p value calculated with mixed effects testing with read depth as
the random effect.
(C) Principal coordinates analysis (PCoA) plots on Unifrac distance of microbial composition for Ctrl and IBS-D.
(D and E) Greater differences in IgA-bound versus unbound bacteria in IBS-D. Unifrac distances between IgA+ and IgA 16S rRNA sequencing for each patient is
shown in (D) (ANOVA with Tukey’s) and for IgA-hi/lo subsets of IBS-D in (E) (Student’s t test; IgA-lo = 24, IgA-hi = 19).
(F) IgA-enriched OTUs in IBS-D. OTUs are selected based on being IgA enriched by both DESeq2 and LEfSe analysis. See also Figures S5F and S5G. Note that
the samples with 0 in IgA+ and IgA subsets are not plotted.
Kruskal Wallis with Dunn’s test, and in parentheses, Mann-WhitneyU between Ctrl and IBS-D; *p < 0.05, **p < 0.005, and ***p < 0.0005. Each experiment on each
patient performed once. See also Figure S5.
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To determine the OTUs that were enriched in the Ig+ subset in
control or IBS-D (STL + ROC) patients, we compared the Ig+ and
Ig 16S rRNA-seq data per group using LEfSe and DESeq2. We
focused on the intersection of these Ig-enriched OTUs with both
methods using the reasoning that they would represent the most
reliably Ig-enriched OTUs (Figure S5G). Many of these OTUs
were Ig enriched in both control and IBS-D patients (Figures
S5G and S5H), as expected based on previous results in other
patient groups.33–35 However, there were a number of OTUs
specifically Ig enriched in IBS-D versus control patients,
including 6 from the Clostridiales order (Figure 5F; Lachnospira-
ceae, Clostridium, Blautia, and Ruminococcaceae), of which 4
are Lachnospiraceae (including Blautia). Subgroup analysis of
IBS-D IgA-hi and IgA-lo (Figure S5G) revealed that 2 OTUs, in
particular an unc. Ruminococcaceae, were preferentially Ig en-
riched in the IgA-hi subgroup (Figure 5F; 2nd in top row, 1st in bot-
tom row). However, these IgA-enriched OTUs in our IBS-D
patients were not related to taxa identified by Liu et al.46 of genus
Escherichia-shigella, Granulicatella, and Haemophilus (Fig-
ure S5I). This may be attributed to differences between the
studies related to our use of fluorescence-activated cell sorting
(FACS) versus magnetic-activated cell sorting (MACS),46 as
well as the geography of the patient cohorts affecting diet and
genetics.
Notably, the IgA-enriched OTUs by LEfSe/DESeq2 showed no
overlap between IBS-D (Figure S5G) and IBD35 if the OTUs IgA
enriched in controls were excluded. Two taxa were increased
in IgA targeting in bothmurine stress and human IBS-D: Verruco-
microbiaceae (genus Akkermansia) and Lachnospiraceae (genus
unc. and Blautia) (Figures 4H and 5F). Thus, these OTU level an-
alyses suggest that IBS-D is associated with a specific Ig
response against bacterial taxa that is different than that seen
in control or IBD patients and with some overlap with murine
stress model.
IgA Antibacterial Immunity Is Better than Dysbiosis as a
Predictor of IBS-D
After finding differences between IBS-D and controls in the mi-
crobial communities and the host:commensal response (Figures
5A and 5D–5F), we sought to understand whether individual
OTUs or taxa have a predictive ability in delineating clinical pop-
ulations. Anticipated limitations to this approach included the
realization that this approach would not be applicable to individ-
uals that do not harbor the bacteria, an important issue in the hu-
man population. Moreover, analysis of OTUs individually would
not reveal coordinated Ig responses within a patient against a
set of bacteria. We therefore turned to machine learning to test
whether Ig enrichment can be used to predict disease. As dis-
cussed above, we used GBM to generate prediction values for
binomial outcomes, which range from 0 to 1 for a given compar-
ison, with values closer to 0 or 1 representing a greater ‘‘confi-
dence’’ of prediction (i.e., control versus IBS-D).
We assessed the ability of GBM to distinguish between IBS-D
and control patients using OTU frequency or Ig-enrichment ra-
tios (log2(% Ig+/% Ig); see Method Details). While it was clear
that the distribution of GBM prediction values were statistically
different between diseases, there was a substantial overlap
when OTU frequency values (i.e., analysis for dysbiosis) were
used (Figures 6A, upper left, and S6A). By contrast, prediction
values based on Ig-enrichment ratios were more distinct, allow-
ing for clearer separation between control and IBS-D patients
(Figure 6A, upper right). It is notable that a subset of control pa-
tients have predictions that overlap with those from IBS-D pa-
tients, which is consistent with the potential for underreporting
IBS in the general population, the knownmechanistic and clinical
heterogeneity of IBS-D, and the lack of objective testing to
establish a diagnosis of IBS-D.16,22 A difference between IBS-
D and control patients was also seen when dada2 amplicon
sequence variant (ASV) data were used (Figure S6B). Interest-
ingly, the clustering of ASVs improved GBM discrimination be-
tween IBS-D and control, suggesting that closely related 16S
rRNA ASVs behaved similarly (Figure S6B). Thus, these data
suggest that there are clearly discernable features of Ig-enriched
bacteria in IBS-D patients as compared to control patients.
The OTUs that formed the basis of these predictions (relative
influence) mostly differed between OTU frequency versus Ig-
enrichment ratios, with only 3 OTUs shared among the top 15
for relative influence (Figure 6B). Many of the OTUs exerting
the highest relative influence for Ig enrichment (Figure 6B; red
dots by taxonomy) were also seen by direct comparisons of
Ig+ versus IgOTU frequencies using LEfSe/DESeq2 (Figure 5F).
Moreover, Ig-enrichment ratios reveal more distinct changes
between IBS-D and control patients than analysis of dysbiosis
using OTU frequency, with a substantially higher area under
the curve (AUC; 0.84 versus 0.7, respectively; Figure 6C). Lastly,
the frequency of IgA+ and IgG+ bacteria in the feces was clearly
associated with stronger IBS-D prediction values, as only IBS-D
patients with normal frequencies of Ig-bound bacteria would be
classified as control patients by GBM (Figure 6D). The correla-
tion between Ig-bound bacterial frequency and the ability of
GBM to predict IBS-D using Ig-enrichment ratios further sup-
ports the notion that host:commensal immunity is altered in
IBS-D. These data therefore suggest that Ig-enrichment ratios
can offer a different perspective on host:commensal interac-
tions independent of assessments of dysbiosis using OTU
frequency.
Clear Differences in Bacterial Composition and Ig
Reactivity between IBS-D and IBD
By contrast, IBS-D was easily distinguished from IBD using OTU
frequency as well as Ig-enrichment ratios (Figure 6A, bottom).
The OTUs with highest relative influence in this model differ
from control versus IBS-D analysis, consistent with the notion
that these are distinct disease entities (Figure S6C). However,
there was a small subset of IBS-D patients who appeared to
be classified as IBD based on OTU frequency and/or Ig enrich-
ment (Figures 6A and S6D). It is currently unclear whether this
is due to the known set of IBD patients who are thought to
have concurrent IBS,48,49 thus affecting our prediction modeling
algorithm, a pre-disease state (antibody without overt dis-
ease),50 and/or normal heterogeneity among IBS-D patients
such that some have Ig enrichment and/or dysbiosis consistent
with IBD, and vice versa. However, the vast majority of IBS-D
and IBD patients exhibit clearly distinguishing features in OTU
frequency and Ig enrichment, with AUC both >0.9 (Figure 6C).
In summary, these data suggest that the dysbiosis and the
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Figure 6. Predictive Value of IgA Response for IBS-D
(A–F) Machine learning (GBM) evaluation of IBS-D using OTU frequency versus Ig ratio data (see Method Details) using data from Figure 5.
(A) Average prediction values for OTU frequency and Ig-enrichment ratios for Ctrl versus IBS-D, and IBS-D versus IBD (Student’s t test). Note that Ig enrichment is
used as IBD patients have IgG+IgA bacteria.
(B) OTUs with the greatest relative influence differ between GBMmodeling using OTU frequency versus Ig ratios. Average relative influence values are shown for
Ctrl versus IBS-D comparisons with the indicated dataset. The red dots by the OTU name indicate bacteria identified as IgA enriched (Figure 5F).
(C) IgA ratios have a higher area under the curve (AUC) than the OTU frequency for predicting IBS-D versus Ctrl. AUC curves are shown for the indicated
comparisons between patient groups using the OTU frequency or Ig ratio data.
(D) Association of IgA frequency with correct disease prediction. GBM prediction values are plotted against IgA/G-bound bacterial percentage.
(E) Correlation of IBS-D prediction with PHQ-15 and HADS anxiety scores. Linear regression analysis of PHQ-15 (subset of STL, n = 12 patients who returned
survey) or HADS anxiety (STL + ROC, n = 12 + 22 patients who returned survey) scores versus GBM prediction values fromOTU frequency or IgA ratios is shown.
*p < 0.05, **p < 0.005, and ****p < 0.00005. Each experiment on each patient performed once. See also Figures S6 and S7.
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targets of the antibacterial B cell response in IBD is distinct from
that seen in IBS-D.
Association of Host:Commensal Immunity with Stress in
IBS-D
Since our murine studies suggested that stress-induced dysbio-
sis can lead to increase IgA-bound bacteria and induce signs of
diarrhea—all features observed in IBS-D patients—we asked
whether we could quantify stress in humans and correlate that
with features of IBS-D. We noted that the assessment of soma-
tization (Patient Health Questionnaire-15 [PHQ-15], STL, n = 12
patients who returned the survey) or anxiety (Hospital Anxiety
and Depression Scale [HADS] anxiety, STL + ROC, n = 12 and
22 patients, respectively, who returned the survey) correlated
with the GBM prediction value for IBS-D derived from Ig-enrich-
ment ratios but not OTU frequency (Figures 6E and 6F). This cor-
relation was not seen with a measure of depression (HADS
depression, STL + ROC, n = 12 and 18, respectively) or symptom
severity score (SSscore, STL + ROC, n = 14 and 19, respectively)
(Figure S7A). Antidepressant use was associated with stronger
IBS-D GBM prediction values (Figure S7B). There were too few
cases of post-infectious IBS-D for interpretation (Figure S7C).
However, there was no clear association of age, body mass in-
dex (BMI), or year of diagnosis with GBM prediction (Figures
S7C and S7D). Nonetheless, the data from IBS-D patients
show notable parallels with experimental stress in mice and sup-
port the model that stress can lead to alterations in gut bacteria
and host homeostasis, physiology, and immunity.
DISCUSSION
These data from both murine models and human disease sug-
gest that physiologic stress can alter intestinal host:commensal
homeostasis and immunity. First, we observed that a murine
stress model can induce significant changes in the microbiota.
Dysbiosis is also seen in IBS-D, a syndrome associated with
stress. Second, stress-induced dysbiosis in mice is sufficient
to induce signs of diarrhea. Bacteria from IBS-D patients have
also been shown to induce features of IBS-D when transferred
into mice.21 Third, stress-induced dysbiosis in mice triggered
the development of bacterial translocation via GAPs and
increased IgA responses to commensal bacteria. IBS-D pa-
tients also exhibited increased IgA responses compared with
control patients. Finally, stress in mice induced an antigen-spe-
cific immune response in a select group of commensal bacteria.
IBS-D patients also exhibited increased IgA responses to bac-
teria in related taxa. Although IBD also shows increased IgA-
bound bacteria, the taxa targeted by IBS-D is mostly distinct
from that of IBD, suggesting a different pathophysiology.
Notably, the anticommensal IgA response was a better predic-
tor of IBS-D than bacterial frequency and was better correlated
with surrogate indicators of widespread pain experiences and
anxiety.
Using amurine restraint model, we showed that stress induces
dysbiosis and bacterial translocation. These data are consistent
with prior publications on themicrobiota13,51 and bacterial trans-
location,36,52,53 although it is notable that markedly longer pe-
riods of stress—up to 8 h/day—were used than the 2 h used in
our study. We link these observations together by showing that
stress-induced dysbiosis leads to the opening of GAPs, a mech-
anism that is well established to result in bacterial translocation
and an enhancement of adaptive immune responses to luminal
substances. While our data suggest that dysbiosis itself is suffi-
cient to induce these changes, it remains probable that stress
contributes to alterations in gut homeostasis via direct effects
on the nervous system, neuromodulators such as ACh, which
could affect gut motility, hypersensitivity, or permeability,54–56
and immunomodulators such as corticosteroids, which could
affect immunity and inhibit bacterial killing.57 In addition, it is un-
known whether GAPs open during human stress or in human
IBS-D, and if so, how long after the period of stress, or whether
they are associated with symptoms. Finally, it is not clear
whether these enhanced immune responses in IBS-D directly
contribute to GI dysfunction as in IBD or represent a response
to it. Thus, much remains to be discovered regarding the mech-
anisms by which stress disrupts host:commensal homeostasis
leading to dysbiosis, bacterial translocation, and altered antibac-
terial immunity.
An unexpected observation of this study was that stress could
induce easily detectable immunologic changes as measured by
IgA bound to fecal bacteria in mice. Moreover, IgA-bound bacte-
ria was clearly elevated in almost half of our IBS-D patients and
was consistent with a study by Liu et al.46 Antibacterial IgA re-
sponses in IBS-D were further supported by the machine
learning analysis of fecal IgA-enriched bacterial OTUs. These
metrics showed a 0.82 and 0.84 AUC for %IgA and machine
learning, respectively, in the comparison between IBS-D and
control patients. This is in line with other biomarker studies in
IBS, including antibodies to CdtB and vinculin (AUC 0.81)58
and performed better than fecal microbial analysis in one study
(AUC 0.74).59 We speculate that the subset of patients associ-
ated with enhanced IgA+ frequency and/or altered IgA-bound
bacteria by machine learning represents a distinct IBS-D subset
with stress-induced immunity to gut bacteria. We predict that
these IgA-associated IBS-D patients may exhibit differential
responsiveness to treatment such as antimicrobial therapy22
that may decrease the microbial stimulation of the immune sys-
tem. Future clinical studies with larger cohorts andmultiple med-
ical centers will be required to confirm these results and deter-
mine whether this subset of IgA-associated IBS-D patients
overlap with those expressing anti-CdtB/vinculin antibodies or
exhibit a different pathophysiology, and whether this may be
useful for directing clinical therapy.
The increase in IgA binding to bacteria in IBS-D or murine
stress was also associated with changes in the taxa targeted
by the adaptive immune system. This included taxa from several
different families, some of which were shared between mouse
and human. One of these bacteria, A. mucinophila, is notable
as it has been reported to facilitate tumor immunotherapy in mu-
rine cancer models.60 Akkermansia was also shown to induce
adaptive effector T cell and IgG1 responses during homeostasis
in mice.61 It is intriguing to speculate that this species may
exhibit continual host:commensal interactions that could be
altered by stress. Alterations in the T and B cell immune
response to Akkermansia may then have prolonged effects on
gut homeostasis and physiology.
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In addition to IBS-D, stress has been associated with disease
activity in IBD.11,62 However, we observed little overlap between
the IgA-targeted bacteria in IBS-D and IBD. This would be
consistent with the marked differences in pathophysiology, as
only IBD is associated with frank mucosal inflammation. None-
theless, it may be speculated that the effect of stress on
increased bacterial translocation and immunity seen in mice
may be exacerbated pathogenic antibacterial immune re-
sponses in human IBD patients. Thus, these data may be useful
to reframe the discussion of the effects of stress and somatiza-
tion on the body to include the potential for microbiota-driven
physiologic and immunologic effects that may break homeosta-
sis in not only IBS-D but also IBD and other autoimmune dis-
eases that may be affected by the gut microbiota.63,64
Limitations of the Study
In this study, we use a stressor in mice that appears to pheno-
copy human IBS-D. However, we cannot be certain that this
model recapitulates the human experience. First, we acknowl-
edge that the diarrheal phenotype observed may be modest,
but it is unknown whether increasing stress would more faithfully
mimic human disease. Second, while both human IBS-D pa-
tients and stressed mice exhibit dysbiosis, the mechanisms by
which this occurs may differ and this is not addressed by this
study. Third, while fecal transplant of stressed microbiota into
GF mice can recapitulate many of the effects of stress in mice
on our measured parameters, we did not test for increased
visceral hypersensitivity, which may be similar to the increased
anxiety-like behavior seen in mice transplanted with human
IBS-D microbiota.21 Finally, while GAPs likely play a role in im-
mune activation during murine stress, it is unclear the extent
GAPs contribute to GI dysfunction in mice, and whether GAPs
are involved in human IBS-D. Thus, while the murine model pro-
vides proof of principle that stress can induce features of IBS-D,
caution must be exercised in making causal claims to human
disease.
Our human studies were performed on a relatively small num-
ber of patients, limiting our ability to generalize these results.
Although the increased frequency of IgA+ bacteria in IBS-D
was supported by another study from China,33 the IgA-targeted
taxa appeared to differ. Another unresolved question is whether
stress/anxiety itself is sufficient to trigger increased IgA-bound
bacteria without IBS-D symptoms. Finally, the immune changes
in IBS-D as reflected by IgA-bound bacteria clearly occur in a
subset of patients, but their impact on triggering or maintaining
the symptoms of IBS-D remains unclear. Thus, future studies
are required to address these questions on the role of stress
on host:commensal immunity and GI function.
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respectively). C57BL/6J gnotobiotic mice were maintained in flexible plastic isolators on a strict 12h light cycle and mice were
weaned onto autoclaved, standard mouse chow diet (Lab Diet 5053). Cages were changed every week by husbandry staff. All cages
were randomly assigned into different treatment groups. Males and females were used equally in all experiments except for abdom-
inal hypersensitivity due to availability at the contributing authors’ facility. No analysis on influence of sex was performed due to inad-
equate sample sizes. All experiments were performed independently at least two times unless otherwise stated.
Human subjects
All human stool specimen and medical data were collected with institutional review board compliance at Washington University
in St. Louis, MO, University of Maryland, Baltimore, MD, andMayo Clinic, Rochester, MN. Inclusion criteria for Celiac Sprue, Rheu-
matoid arthritis, Crohn’s disease and ulcerative colitis patients were physician’s diagnosis of disease supported by appropriate
laboratory measures. Inclusion criteria for IBS-D subjects included patient symptoms of abdominal pain associated with diar-
rheal-predominant bowel pattern, consistent with Rome III diagnostic criteria.81 Exclusion criteria for all IBS and controls included
antibiotic treatment in the last month and diagnosis of any other concurrent gastrointestinal disease, including intestinal resec-
tions. We attempted to obtain the PHQ15,82 IBS-symptom severity score (IBS-SSS)83 and the Hospital Anxiety and Depression
Scale (HADS)84 from all IBS patients; however, only a random subset returned these questionnaires. Cohort data are detailed
in Tables S1 and S2 and Data S1.
METHOD DETAILS
OTII expansion
FACS-purified 105 naive (CD4+Foxp3-CD25-CD62LhiCD44lo) Rag1–/–OTII from cdMLN cells were injected retro-orbitally, followed by
25 mg/mouse ovalbumin enema the following day, and analyzed 3 days later by flow cytometry. Cells from the cdMLN were stained
with anti-CD4 BV700 (Biolegend), anti-CD45.1 A700 (Biolegend), anti-Va2 APC-Cy7 (Biolegend) and anti-CD45.2 PE (Biolegend), and
analyzed on a FACSAria IIu.
CT2 transfers
FACS-purified 105 naive (CD4+Foxp3-CD25-CD62LhiCD44lo) from CD45.2 Foxp3Thy1.1Rag1/ TCR Tg mice (CT2) were injected
retro-orbital in stressed mice on d5 of stress into congenic CD45.1 Foxp3gfp mice, and analyzed 3 days later by flow cytometry. Cells
from cdMLN were stained with anit-CD4 BV700 (Biolegend), anti-CD45.2 PE (Biolegend), anit-CD45.1 A700 (Biolegend), cell trace
violet PB (Invitrogen), anti-Thy1.1 PECy7 (Biolegend), anti-CD25 PerCP-Cy5.5 (Biolegend), anti-CD44 AF430 (Biolegend), anti-
CXCR3 (APC). Divided transferred cells were identified as CD4+CD45.2+CD45.1-Va2+PB+ . Treg of divided TCR+ cells identified
as % of Thy1.1+ cells among transferred cells. Host T cells were identified as CD4+CD45.1+CD45.2- .
Bacterial FACS and sequencing
Mouse terminal fecal pellets were frozen at 80C in screw-cap tubes until FACS-sorting. For human fecal specimens, a ~20mg
chip of stool was obtained from a stool aliquot stored at80C. Samples were analyzed by flow cytometry as described.35 Briefly,
fecal samples dissolved in PBS by vortexing and sonication. After centrifugation, the supernatant was frozen for free fecal IgA
measurements by IgA ELISA as described.35 The pellet was resuspended in 5 mM N-acetyl-cysteine to break disulfide bonds
in mucus and release bacteria. After washing, the samples were blocked with 20% FBS, then stained with DAPI, IgG FITC isotype,
anti-IgA(APC), and IgG(PE) antibodies (Abcam), filtered through a 35 mm filter and analyzed by flow cytometery (FACSAria IIu).
200,000 events in the input were used for OTU frequency analysis, and 30,000 Ig-bound and unbound fractions were FACS-sorted
for each sample. Sort-purity for Ig-bound bacteria was generally between 65 - 75%. To decrease contamination, ethanol was run
through the cytometer during fluidics shutdown and autoclaved PBS was used as sheath fluid. Sheath fluid was also sorted and
sequenced separately to identify any contaminant OTUs which were removed during data processing. A Pseudomonas spp.
S27630 was the predominant contaminant in sheath fluid and was removed from all analysis as it is not a common gut inhabitant.85
A PCR reaction was set up in triplicate using 2 mL of concentrated bacteria/tube to amplify bacterial V4 hypervariable region of 16S
rRNA using barcoded primers described previously.43 Pooled PCR products were sequenced using the Illumina MiSeq platform
(2 3 250-bp paired-end reads).
16S rRNA analysis
OTU picking was performed as before35 using UPARSE (usearch v9, radius = 3%)66 based on a calculated OTU frequency that com-
bines the sequencing data with the proportions obtained by flow cytometry per specimen. Taxonomy was based on species desig-
nations with > 97% confidence using Seqmatch or from the Ribosomal Database Project (RDP v2.6)67 classifier using default set-
tings. 16S microbial composition analysis was performed on input sorted fraction using the using phyloseq (v1.19.1)68 in R after
rarefaction. Unifrac or Bray-Curtis distance matrixes were calculated in phyloseq. Significance was calculated using the adonis
call in vegan (v2.4-4 in R).69 For a subset of analyses, dada2 ASVs (v.1.12)86 were used. Clustering of ASVs was performed by
size using UPARSE.
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Analysis of Ig-enriched taxa
IgA-enrichment of a particular taxa is calculated as: Log2(% OTU in IgA+ /% OTU in IgA–). IgA-enrichment indices were arbitrarily
capped at 5.61 (log2(ratio of 49)) or 5.61 for taxa present only in IgA+ or IgA– fraction. For taxa that were entirely absent in a fecal
specimen, an ‘‘NA’’ was assigned. To account for sequencing errors and imperfect bacterial sorting purity, only OTUs with frequency
> = 1/5000 counts were analyzed. To study generally relevant bacteria, only taxa present in > 25% of individuals in the group were
analyzed. DESeq2 (v1.24 in R; using sfType = ’’poscounts’’)70 and LEfSe87 were used to compare Ig+ and Ig– sequencing data within
sample.
Gradient boosted machine
Random forest is a machine learning algorithm commonly used to look at differences in the microbiome between groups,88 but does
not handle NAs (not available) in the data intrinsically. While this is not an issue with absent taxa in the analysis of OTU frequency as it
would be 0, absent taxa in IgA enrichment data would be represented by an NA. We therefore used gradient boosted machine
modeling (gbm R package v2.1.5)71 to evaluate the bernoulli distribution with 5 fold cross-validation for all 16S or Ig enrichment
data between two disease groups. To ensure that the approach was applicable across all the data, multiple trials were performed
in which each trial was trained with a random 75% of the fecal specimens without replacement and tested against the remaining
25%. Optimization of n.minobsinnode, bag.fraction, and interaction.depth for area under the curve (AUC, pROC v 1.10.0)72 was per-
formed on 20-40 trials for each set of parameters. N.trees was set at 10000, which was typically > two-fold higher than the optimum
number determined by gbm. The final analysis used 160 trials to generate average prediction values per sample from ~40 trials as
each sample is only in 1/4 of the trials in the test fraction, whereas relative influence of OTUs are from 160 trials.
Abdominal Mechanical Sensitivity
Somatic hyperalgesia was assessed by von Frey filaments as described previously.65,89 Briefly, the abdomenwas shaved prior to the
start of restraint stress. One day after the last stress, animals were placed on a metal screen mesh in individual enclosures. After 1
hour of acclimation in the presence of white noise, mice received 5 separate stimulations with each von Frey filament (North Coast
Medical Inc.; 0.02, 0.08, 0.32 and 1.28 g), with > 15 s pauses between stimulations and > 5 m when switching filament size. The
assessor of response to stimulation was blinded to the experimental group.
Modulation of motility and stress
To induce diarrhea, mice were administered 10 mg cholera toxin (Sigma) in 100 mL of PBS or PBS alone on d1 and d4 per rectal enema
using a flexible 1.5’’ IV catheter. Mice were subjected to experimental stress through physical restraint in 50ml conical tubes with
adequate ventilation for 2 hours/day on 7 consecutive days.28 During those 2 hours, food and water were withheld from control mice.
FMT experiments
Cecal contents were pooled between 3-5 mice, resuspended in 2ml of sterile PBS, filtered with a 70 mM filter. Bacterial load was
standardized between stressed and control contents by 16S real time PCR with F-50-GGTGAATACGTTCCCGG-30 and R-50-
TACGGCTACCTTGTTACGACTT-30 primers.65 FMTs in stressed SPFmice were performed per-rectum at the end of the 2 hour stress
cycle for all 7 days. FMT in GF mice were performed by a single oral gavage of 100 mL of cecal contents.
Diarrhea signs
Fecal output wasmeasured counting the number of pellets produced by individual mice after 2 hours in an empty ice-cream container
covered with a cage top for adequate ventilation. To calculate fecal water weight, a terminal fecal pellet was immediately stored in a
sealed screw-cap tube, weighed on aluminum foil soon after collection, and then re-measured after drying at 80Cdegrees overnight.
The percentage of water is obtained from the ratio of dry/pre-baked weights.
Colon histology
Mouse colons were harvested and luminal contents removed with PBS washing, fixed, and stained by H&E. Colons were assessed
for histologic inflammation (ulceration, mononuclear cell infiltration and edema) in a blinded fashion by a gastroenterologist and digital
photographs were taken.
Bacterial translocation
As previously described,90 lymph nodes were homogenized in a Bullet Blender (Next Advance) for 3 minutes. 100 mL of homogenate
was plated onto aerobic Luria-Bertani (LB) agar plates and incubated at 37C overnight prior to colony counting.
GAP measurement
GAPswere measured as previously described.38 Briefly, colon tissue was incubated with 100 mg lysine fixable tetramethylrhodamine
labeled 10 kd dextran (Invitrogen) prior to fixation, blocking, DAPI staining, and sectioning. GAPs were identified as dextran-filled
columns traversing the epithelium and containing a nucleus. In some experiments atropine chloride (pan-mAChR antagonist
500 mg/ml Sigma-Aldrich), tropicamide (mAChR4 selective antagonist, 100 mg/ml Sigma-Aldrich), LPS (10 mg/ml, Sigma-Aldrich),
Cell Reports Medicine 1, 100124, October 20, 2020 e4
Article
ll
OPEN ACCESS
recombinant murine epidermal growth factor (10 mg/ml Shenandoah), or cecal contents was added to the colonic explant culture. For
EGF treatments, mice were administered per-rectum with either 100ul volume of PBS or 1ug of EGF (Shenandoah Biotech) in 100ul
PBS at the end of the 2 hour stress cycle for all 7 days. For EGFRi experiments, unstressed adult mice were given intraperitoneal
EGFRi (500ug/kg tryphostin AG 1478) injections or PBS vehicle for 7 days and then fecal pellets collected on day 8 for bacterial FACS.
RNA seq
Whole colon and cecum were harvested frommice, luminal contents removed, and tissue washed thoroughly with PBS before snap
freezing at 100 mg tissue/ml of TRIzol (Invitrogen). RNA was prepared using the Takara SMARTer Stranded Total RNA Sample Prep
Kit – Hi Mammalian for sequencing on a HiSeq 3000 (50bp single end). RNA-seq reads were aligned to the Ensembl release 76 top-
level assembly with STAR v2.0.4b.73 Gene counts were derived from the number of uniquely aligned unambiguous reads by Sub-
read:featureCount version 1.4.5. Transcript counts were produced by Sailfish version 0.6.3.74 Sequencing performance was as-
sessed for total number of aligned reads, total number of uniquely aligned reads, genes and transcripts detected, ribosomal fraction
known junction saturation and read distribution over known gene models with RSeQC version 2.3.75 All gene-level and transcript
counts were then imported into the R/Bioconductor package EdgeR76,77 and TMM normalization size factors were calculated to
adjust samples for differences in library size. Genes or transcripts not expressed in any sample or less than one count-per-million
in the minimum group size minus one were excluded from further analysis. The TMM size factors and the matrix of counts were
then imported into R/Bioconductor package Limma80 and weighted likelihoods based on the observed mean-variance relationship
of every gene/transcript and sample were then calculated for all samples with the voomWithQualityWeights function. Gene/transcript
performance was assessed with plots of residual standard deviation of every gene to their average log-count with a robustly fitted
trend line of the residuals. Generalized linear models were then created to test for gene/transcript level differential expression. To
enhance the biological interpretation of the large set of transcripts, grouping of genes/transcripts based on functional similarity
and generation of pathway maps on known signaling and metabolism pathways curated by GO, was achieved using the R/Bio-
conductor packages GAGE91 and Pathview.78
QUANTIFICATION AND STATISTICAL ANALYSIS
GraphPad Prism v8, R v3.6, QIIME v1.9.179 were used for statistical and graphical analysis. Student’s t test, Mann-Whitney U test,
Kruskal Wallis test, generalized linear model (GLM), Pearson’s correlations were used for between-subjects and continuous data
analyses. Non-parametric Mann-Whitney U and Kruskal Wallis tests were used only on 16S data where normal distribution cannot
be assumed. Benjamini-Hochberg multiple testing correction, as noted by padj, were performed using the base stats package in R.
Each figure legend details the statistical test use, value of n and SD if applicable, how significance was defined (* for p < 0.05, ** for p <
0.005, *** for p < 0.0005, unless otherwise specified).
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Figure S1. Immunity and stress, related to Figure 1.  (A) T cell populations with stress. CD4+ T cell populations 
were analyzed by flow cytometry on d8 with or without stress as per Figure 1A (left). Representative shematic of 
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flow-cytometric gating (right). Data shown are gated on host CD4+ T cells (n=6-8 from 2 experiments).  (B) 
Schematic of flow-cytometric gating for % of Treg of divided transferred congenitally marked naïve CT2 cells, 
related to Figure 1D. (C) Characterization of transferred CT2 cells with stress, related to Figure 1D (left).  
Representative schematic of flow cytometric gating of transferred congenically marked naïve CT2 T cells showing 
expression of CD25, CD44, and cell division (Cell Trace Violet dilution) (right) (n=6-8 from 2 experiments). (D) 
Representative schematic of flow-cytometric bacterial sorting with representative IBD specimen. All events that fall 
within the FSC and SSC gate were sorted as “Input.”  Bacterial events were gated based on DAPI staining and lack 
of auto-fluorescence (PerCP-Cy5.5 and PE/Texas Red) and isotype-control antibody staining. Depending on the 
presence of IgA+ or IgG+ events, two to four fractions were sorted from each sample: IgA–IgG–, IgA+IgG–, IgA–IgG+ 
and IgA+IgG+. (E) Free fecal IgA with stress, related to Figure 1E. One day after the last stress, fecal pellets were 
washed, spun down, and the concentration of IgA in the supernatant assessed by ELISA (n=8-9 from 2 
experiments).  (F) Representative schematic of flow-cytometric gating of % of congenically marked transferred 
OTII cells of all CD4+ cells. Data shown are mean +/- S.E.M. and analyzed by Student’s t-test. 
 
 
Figure S2. Effects of stress microbiota on germ-free mice, related to Figure 3. Bacterial translocation and 
increased IgA-bound bacteria persist in germ-free mice transplanted with stress microbiota, related to Figure 3C-E. 
Mice were analyzed at the indicated times after transplant of stressed or control cecal contents (CC) into mice 
without additional stress (n=6-8 from 2 experiments). Data were analyzed by Student’s t-test. *P< 0.05.  
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Figure S3. Dysbiosis induced stress drives immunological alterations, related to Figure 3F. GF and SPF mice 
were stressed for 7 days. The following day, the entire colon and cecum with respective un-stressed controls was 
analyzed by RNA-Seq (n=3/group, 1 expt). (Top) The top 20 Gene Ontology processes or differentially expressed 
genes by significance (all padj < 0.05) between stressed vs control GF mice are shown as per Figure 3F. (Bottom) 
All Gene Ontology processes created with Pathview with GAGE padj<0.05 were chosen for display split by the 
number of upregulated or downregulated processed in SPF stressed vs. GF stressed mice and binned into the 
displayed general categories (left). Top 10 most significant genes (padj<0.05) that were upregulated or 
downregulated in SPF stressed vs. GF stressed mice with colors indicating the Gene Ontology processes categories 
in legend (lower left). All pathways with the category designations and involved gene can be found in 
Supplementary File 2.  
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Figure S4. Microbial changes with stress, related to Figure 4.  (A) Differentially enriched OTUs. Heatmap 
representation of bacterial frequency changes with stress (Mann Whitney U padj <0.1 for all 3 time points), related 
to Figure 4D-F. Mice were stressed as per Figure 1A and the terminal fecal pellet was analyzed by 16S rRNA 
sequencing on the indicated days (n=8-9). (B) Identification of bacteria increased in the IgA+ vs IgA– fraction. 16S 
rRNA data were analyzed by DESeq2 and LEfSe. The intersection of the OTUs enriched in the IgA+ fraction in 
stressed but not control mice are show as the top 2 OTUs, with the OTUs found IgA-enriched in both stress and 
control below. OTUs with the red dot are shown in Figure 4H, or otherwise shown on the right. (n=24-28, pooled 
d8, d14, d21 data; samples with 0 in IgA+ and IgA– subsets not plotted). Mann Whitney U test and two to three 
independent experiments for all panels unless otherwise specified.  
Figure S5. IBS-D associated changes in IgA-bound bacteria, related to Figure 5.  (A) IgA-bound bacteria are 
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cytometry of fecal samples from RA patients (STL, n=11) or Celiac sprue (Baltimore, n=37). Kruskal Wallis with 
Dunn’s test. (B) Increased IgA-bound bacteria in IBS-D is independent of geography and medical center, related to 
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respectively). Student’s t-test between STL and ROC samples. (C) Increased free fecal IgA in IBS-D. Fecal samples 
were diluted in PBS, mixed, and centrifuged. The supernatant was analyzed for IgA by ELISA. Mann Whitney U 
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Top OTUs were significant only in IBS-D, whereas bottom OTUs were IgA-enriched in both Ctrl and IBS-D. (H) 
IgA enrichment of individual OTUs in (G) not shown in Figure 5F. Kruskal Wallis with Dunn’s test (Ctrl =34, IBS-
D=43, IBD=43, IgA-lo=24, IgA-hi=19). (I) IgA-enrichment of taxa related to Liu et al.47 Note that Granulicatella 
was found in the dada2 ASVs and not UPARSE OTUs. Mann Whitney U P-values are shown (Ctrl=34, IBS-D=43).  
Samples with 0 in IgA+ and IgA– subsets not plotted in (H-I). *P < 0.05, ****P < 0.00005. Each experiment on 
each patient performed once. 
 
  
 
Figure S6. Machine learning prediction of IBS-D, related to Figure 6.  (A) Gbm prediction using OTU 
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frequency, Ig enrichment ratios, or both. Data shown are IBS-D prediction values when modeled against Ctrl or 
IBS-D as per Figure 6A (contains data from Figure 6A for reference). (B) Gbm prediction using dada2 ASVs. ASVs 
were also clustered using UPARSE at the indicated percent identity (97-99%) and used for gbm prediction. Data 
from Figure 6A is shown for direct comparison. The relationship between clustering of ASVs and gbm prediction 
AUC is shown in the lower left. An example of how ASVs may reduce power compared to clustered OTUs is shown 
in the lower right for Akkermansia. (C) The top 15 OTUs for average relative influence in the gbm models generated 
between IBS-D vs Ctrl or IBD as per Figure 6A. The average relative influence of the OTU in the other comparison 
is also shown. (D) Comparison of IBS-D vs Ctrl or IBD gbm prediction values. IBS-D (red), Ctrl (black), or IBD 
(blue) gbm prediction values (Ctrl=34, IBS-D=43, IBD=43 for all experiments). *P<0.05, **P< 0.005, 
***P<0.0005, ****P<0.00005. Each experiment on each patient performed once. 
 
  
Figure S7. Clinical characteristics of IgA-associated IBS-D patients, related to Figure 6.  (A) Comparison of 
gbm prediction values with SSscore (STL+ROC, n=14,19) and HADdepression (STL+ROC, n=12,18) values and 
modeled by linear regression. (B) STL patients on anti-depressants show higher gbm prediction values for IBS-D. 
(No anti-depr. = 9, tricyclic = 5, SSRI = 2, both = 2; +anti-depr. = 9, -anti-depr.=9). Student’s t-test excluding 
patients with C. diff. history (Hx) P=0.0004, +anti-depr. = 8, -anti-depr.= 8 (P=0.02 if included). (C) No correlation 
of gbm prediction with duration of diagnosis, n=42 patients returned survey. Gbm prediction and IgA% is shown for 
infection associated diarrhea, but the low number of cases precludes statistical analysis. (No Hx = 38, C. diff Hx = 2, 
Infection Hx = 2) (D) No correlation of gbm prediction with age or BMI (IBS-D/BMI = 41, IBS-D/Age = 43, 
Ctrl/BMI = 33, Ctrl/Age = 34).  *P<0.05, ***P< 0.0005. Each experiment on each patient performed once. 
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Table S1: Patient demographics, related to Figure 5 and Figure 6 
IBS-D: diarrhea predominant Irritable bowel syndrome.  
IBD: Inflammatory bowel disease  
N.D.: No data available  
Data presented as mean ± S.D.  
 
  
 Control/Non-IBS IBS-D RA Celiac IBD 
Cohort STL ROC STL ROC STL BAL STL 
Number 21 13 20 23 11 37 43 
% Female 76.2 76.9 80.0 70.0 90.0 81.1 64.7 
Age 53.0 ± 17.5  35.7 ± 11.1 52.1 ± 14.2  
38.3 ± 
12.6  
59.1 ± 
12.6  
39.7 ± 
12.5  
45.2 
±15.7  
BMI (n) 21.7 ± 2.7 (20) 
25.7 ± 3.3 
(13) 
30.6 ± 
9.3 
(17) 
27.8 ± 
7.5 
(23) 
27.5 ± 
7.4 
(11) 
N.D. 
26.7 ± 
6.6 
(40) 
Race 
% Caucasian 
% African American 
% Other 
 
66.7 
19.1 
14.7 
 
84.6 
0 
15.4 
 
100 
0 
0 
 
100 
0 
0 
 
54.5 
45.5 
0 
 
100 
0 
0 
 
93.0 
6.9 
0 
 
 
 
 
Table S2: Infectious colitis history in IBS patients  
#: Patient endorsed or chart documented history of infectious colitis > 30 days prior to stool specimen collection  
 
 
 Control/NonIBS IBS-D 
Cohort STL ROC STL ROC 
Infectious colitis# history 
(n (% of total)) 0 (0%) 0 (0%) 4 (20%) 0 (0%) 
